National Comprehensive Cancer Network



About NCCN

Esophageal/Gastric Cancers Panel - Disclosures as of 9/27/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jaffer A. Ajani, MD

Bayer HealthCare;
ImClone Systems Incorporated;
Ascenta;
Genta;
sanofi-aventis U.S.;
Taiho Parmaceuticals Co., Ltd.

Bristol-Myers Squibb Company;
sanofi-aventis U.S.

None

None

9/12/2011

James S. Barthel, MD

None

None

Merit Medical Endotek

None

3/29/2011

David J. Bentrem, MD, MS

None

None

None

None

10/1/2012

Thomas A. D'Amico, MD

None

Scanlan

None

None

2/28/2013

Prajnan Das, MD, MS, MPH

None

None

None

None

10/1/2012

Crystal S. Denlinger, MD

None

Vicus Pharmaceuticals

None

None

5/11/2012

Charles S. Fuchs, MD, MPH

Amgen Inc.;
ImClone Systems Incorporated

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Genomic Health, Inc.;
GlaxoSmithKline;
ImClone Systems Incorporated;
Merck & Co., Inc.;
Alnylam;
mersana;
Roche Laboratories, Inc.

None

None

6/14/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Hans Gerdes, MD

None

None

None

None

6/29/2012

Robert E. Glasgow, MD

None

None

None

None

8/9/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

James A. Hayman, MD, MBA

None

None

None

None

3/7/2013

Wayne L. Hofstetter, MD

None

None

None

None

3/1/2013

David H. Ilson, MD, PhD

None

None

None

None

10/26/2012

Rajesh N. Keswani, MD

None

None

None

None

8/13/2012

Lawrence R. Kleinberg, MD

None

None

None

None

9/19/2011

W. Michael Korn, MD

None

Celgene Corporation;
Daiichi- Sankyo Co.

None

None

3/14/2012

A. Craig Lockhart, MD, MHS

Amgen Inc.;
Bayer HealthCare;
Cephalon, Inc.;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Allos;
Eli Lilly/ImClone;
Zenyaku;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

None

10/10/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Nicole McMillian, MS

None

None

None

None

3/27/2013

Mary F. Mulcahy, MD

None

None

None

None

1/26/2012

Mark B. Orringer, MD

None

None

None

None

9/18/2012

Raymond U. Osarogiagbon, MD, FACP

Bristol-Myers Squibb Company;
Eli Lilly and Company

Genentech, Inc.;
OSI Pharmaceuticals, Inc.

None

None

6/15/2011

James A. Posey, MD

None

None

None

None

4/16/2010

Aaron R. Sasson, MD

None

None

None

None

10/8/2012

Walter J. Scott, MD, FACS

None

None

Johnson & Johnson

None

6/19/2012

Stephen Shibata, MD

None

Genentech, Inc.;
Genomic Health, Inc.

None

None

6/22/2011

Vivian E. Strong, MD

None

None

None

None

8/26/2012

Hema Sundar, PhD

None

None

None

None

2/25/2013

Thomas K. Varghese, MD

None

None

None

None

2/27/2013

Graham Warren, MD, PhD

None

None

None

None

11/7/2012

Mary Kay Washington, MD, PhD

None

Genentech, Inc.

None

None

10/1/2012

Christopher G. Willett, MD

None

None

None

None

11/14/2012

Cameron D. Wright, MD

None

None

None

None

10/1/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved